Equity Overview
Price & Market Data
Price: $2.30
Daily Change: -$0.05 / 2.17%
Daily Range: $2.25 - $2.35
Market Cap: $90,030,849
Daily Volume: 46,951
Performance Metrics
1 Week: 8.49%
1 Month: 14.43%
3 Months: -34.29%
6 Months: -31.14%
1 Year: -31.14%
YTD: -22.56%
Company Details
Employees: 72
Sector: Health services
Industry: Medical/Nursing services
Country: United States
Details
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.